Clinical Trials in Atlanta

Showing 7101-7120 of 19,805 trials

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

NCT04249778

This study will evaluate the safety and efficacy of dapagliflozin treatment in preventing hospital re-admissions, emergency room (ER) visits, urgent clinic visits, and death in patients with and without type 2 diabetes (T2D) after hospital admission for heart failure.

Heart FailureDiabetes

Emory University105 participantsStarted Jul 2020

Atlanta, Georgia, United States • New Orleans, Louisiana, United States • Philadelphia, Pennsylvania, United States

WITHDRAWNPhase 2< 1 mile

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

NCT06337331

Patients eligible for a mismatch allogeneic stem cell transplant will receive Venetoclax daily for 7 days prior to transplant in addition to the following chemotherapy regimen: Decitabine daily for 5 days, Fludarabine daily for 5 days, and Busulfan daily for 2 days followed by 1 day of total body irradiation. Stem cell transplant will occur thereafter.

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Northside Hospital, Inc.Started Aug 2024

Atlanta, Georgia, United States

COMPLETEDNA5.6 miles

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

NCT03256227

Evidence-based psychotherapies (EBP) for PTSD, such as Prolonged Exposure (PE), result in clinically significant symptom relief for many. Yet, adherence to this treatment (i.e., session attendance and homework compliance), which is vital to ensuring recovery, can be poor. This project will test the effectiveness of improving family support for PE as a tool to improve Veterans' PE adherence. Reducing rates of dropout from PE will positively impact Veterans' health and well-being and lower the cost of treating PTSD. Additionally, despite congressional legislation and national mandates within VA/DoD for family involvement in PTSD care, there remains no proven strategies for how to routinely include family in traditional individual (i.e., one-on-one) EBPs for PTSD. This proposal will provide the initial test of a model of family engagement that can be translated to other problems faced by Veterans, including suicide prevention, traumatic brain injury (TBI) rehabilitation, and pain management, contributing to a broader evolution towards evidence-based, family-inclusive care.

Posttraumatic Stress Disorder

VA Office of Research and Development128 participantsStarted Jan 2018

Decatur, Georgia, United States • Ann Arbor, Michigan, United States • Minneapolis, Minnesota, United States

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

Find Trials by Condition in Atlanta

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

Open-Label Study of Oral Treprostinil in Digital Ulcers

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

A Study of KRN23 in X-linked Hypophosphatemia

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria